NAT2 Gene rs1041983 is Associated with Anti-Tuberculosis Drug Induced Hepatotoxicity Among Pediatric Tuberculosis in

Insights

A specific gene variation, rs1041983 in the NAT2 gene, is linked to a higher risk of drug-induced liver damage in children with tuberculosis. This finding aids in predicting and managing adverse drug reactions in pediatric TB patients.

Area of Science:

  • Pharmacogenomics
  • Pediatric Infectious Diseases
  • Hepatology

Background:

  • Pediatric tuberculosis (TB) diagnosis and treatment present global challenges.
  • Antituberculosis drug-induced hepatotoxicity (ADIH) can impede treatment success.
  • The NAT2 gene, encoding a key enzyme for isoniazid metabolism, is implicated in ADIH, particularly in Asian populations due to specific polymorphisms.

Purpose of the Study:

  • To investigate the association between four single nucleotide polymorphisms (SNPs) in the NAT2 gene and ADIH in pediatric TB patients.
  • To identify specific NAT2 gene variants that predict ADIH risk in children undergoing TB treatment.

Main Methods:

  • A case-control study was conducted with 31 pediatric TB patients experiencing ADIH and 31 controls without ADIH.
  • Genomic DNA was analyzed using PCR and sequencing to identify polymorphisms rs1041983, rs1799929, rs1799930, and rs1799931.
  • Statistical analysis was performed using Epi Info Ver. 7 software.

Main Results:

  • The study identified a significant association between SNP rs1041983 and the occurrence of ADIH in pediatric TB patients (OR 2.39, p=0.019).
  • No significant association was found between ADIH and the NAT2 polymorphisms rs1799929 (p=0.133), rs1799930 (p=0.150), or rs1799931 (p=0.659).

Conclusions:

  • The NAT2 gene polymorphism rs1041983 is significantly associated with the occurrence of ADIH in pediatric TB patients.
  • This finding highlights the potential of rs1041983 as a predictive biomarker for ADIH in this population.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
286
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
442
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
251
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
769
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
563